Ángel María
Alonso Gómez
Brigham and Women's Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Brigham and Women's Hospital (6)
2023
-
Plasma lipidome and risk of atrial fibrillation: results from the PREDIMED trial
Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 355-364
2022
-
Arginine catabolism metabolites and atrial fibrillation or heart failure risk: 2 case-control studies within the Prevención con Dieta Mediterránea (PREDIMED) trial
The American journal of clinical nutrition, Vol. 116, Núm. 3, pp. 653-662
-
Plasma acylcarnitines and risk of incident heart failure and atrial fibrillation: the Prevención con dieta mediterránea study
Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 649-658
2021
-
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study
Clinical chemistry, Vol. 67, Núm. 1, pp. 288-297
-
Metabolomics of the tryptophan-kynurenine degradation pathway and risk of atrial fibrillation and heart failure: potential modification effect of Mediterranean diet
The American journal of clinical nutrition, Vol. 114, Núm. 5, pp. 1646-1654
2019
-
Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: Results from two case-cohort studies
Cardiovascular Diabetology, Vol. 18, Núm. 1